- In March 2026, Aflac Incorporated expanded its Group Life Term to 120 product by adding a hybrid long-term care rider that offers flexible, portable benefits usable for home- or facility-based care, including informal caregiving, though availability still varies by state.
- This innovation reflects Aflac’s push to address the “Silver Tsunami” and rising long-term care costs by letting policyholders tap life coverage during their lifetimes rather than only after death.
- Next, we’ll examine how this new hybrid long-term care rider could influence Aflac’s investment narrative around product innovation and U.S. growth.
Explore 22 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
Aflac Investment Narrative Recap
To own Aflac, you need to believe it can offset pressure from shrinking Japanese premiums and softer U.S. sales with product innovation and disciplined capital returns. The new hybrid long term care rider supports the U.S. growth story, but its financial impact is likely incremental in the near term compared with the bigger swing factors of Japan premium trends, investment income variability and execution in U.S. distribution.
The long term care rider rollout sits alongside Aflac’s broader U.S. initiatives, including its expanded relationship with Empower Brokerage, which opens access to more than 8,000 agents. Together, these moves point to a focus on refreshing products and widening distribution to address concerns about modest U.S. premium growth, while Japan remains the key source of earnings and the largest operational risk.
Yet behind the product innovation, investors should also be aware of the persistent decline in Japanese premiums and...
Read the full narrative on Aflac (it's free!)
Aflac's narrative projects $18.0 billion revenue and $3.8 billion earnings by 2029. This requires 1.5% yearly revenue growth and a $0.2 billion earnings increase from $3.6 billion today.
Uncover how Aflac's forecasts yield a $113.00 fair value, a 6% upside to its current price.
Exploring Other Perspectives
Two fair value estimates from the Simply Wall St Community span about US$113 to roughly US$179 per share, showing how far apart individual views can be. Readers should weigh that spread against ongoing pressure on Japanese premiums and consider how different assumptions about that risk can reshape expectations for Aflac’s long term earnings profile.
Explore 2 other fair value estimates on Aflac - why the stock might be worth as much as 68% more than the current price!
Reach Your Own Conclusion
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
- A great starting point for your Aflac research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
- Our free Aflac research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Aflac's overall financial health at a glance.
Want Some Alternatives?
Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:
- Capitalize on the AI infrastructure supercycle with our selection of the 35 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
- We've uncovered the 12 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
- Invest in the nuclear renaissance through our list of 89 elite nuclear energy infrastructure plays powering the global AI revolution.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com